Nebenwirkungen · Pyzchiva
Pyzchiva 45 mg solution for injection in pre-filled pen Pyzchiva 90 mg solution for injection in pre-filled pen · Abschnitt 4.8 · PDF-Seite 52
HOS-152047 · Präparat HOS-100665
Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system listed in Appendix V.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-07-03T14:40:00Z · SHA-256 24f42a13e263361e45daf03240bd1f30ff701ef234e4b135f72f1f3a44cecfae · Passage 42f7144177697b690f59b1bda795c3fd216297691cf296a2e1269a137feab3cd · Zeichen 8250–8605 im Abschnitt